Cardiovascular mortality and N-terminal-proBNP reduced after combined selenium and coenzyme Q10 supplementation: A 5-year prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens

International Journal of Cardiology

Volumn 167, Issue 5, 2013, Pages 1860-1866

  Alehagen, Urban ^a,c   Johansson, Peter ^a,c   Björnstedt, Mikael ^b   Rosén, Anders ^a   Dahlström, Ulf ^a,c  

^a LINKÖPING UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c Centre of Surgery and Oncology   (Sweden)

Author keywords

Cardiovascular mortality; Coenzyme Q10; Dietary supplementation; Elderly; NT proBNP; Selenium

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; SELENIUM; UBIDECARENONE;

AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CLINICAL PROTOCOL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; ECHOCARDIOGRAPHY; ETHNIC GROUP; FEMALE; FOLLOW UP; HEART DISEASE; HEART FUNCTION; HUMAN; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SWEDISH; TREATMENT RESPONSE;

CARDIOVASCULAR MORTALITY; COENZYME Q10; DIETARY SUPPLEMENTATION; ELDERLY; NT-PROBNP; SELENIUM;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; SELENIUM; SWEDEN; UBIQUINONE;

EID: 84883285659     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.04.156     Document Type: Article

References (34)

1. M.P. Rayman The importance of selenium to human health Lancet 356 9225 2000 233 241
2. M. Selenius, A.K. Rundlöf, E. Olm, A.P. Fernandes, and M. Björnstedt Selenium and the selenoprotein thioredoxin reductase in the prevention, treatment and diagnostics of cancer Antioxid Redox Signal 12 7 2010 867 880
3. S.J. Fairweather-Tait, Y. Bao, and M.R. Broadley Selenium in human health and disease Antioxid Redox Signal 14 7 2011 1337 1383
4. A.J. Goldson, S.J. Fairweather-Tait, and C.N. Armah Effects of selenium supplementation on selenoprotein gene expression and response to influenza vaccine challenge: a randomised controlled trial PLoS One 6 3 2011 e14771
5. M.P. Rayman Selenium in cancer prevention: a review of the evidence and mechanism of action Proc Nutr Soc 64 4 2005 527 542
6. Y.Y. Cheng, and P.C. Qian The effect of selenium-fortified table salt in the prevention of Keshan disease on a population of 1.05 million Biomed Environ Sci 3 4 1990 422 428
7. L.C. Clark, G.F. Combs Jr., and B.W. Turnbull Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group JAMA 276 24 1996 1957 1963
8. J. Bleys, A. Navas-Acien, and M. Laclaustra Serum selenium and peripheral arterial disease: results from the national health and nutrition examination survey, 2003-2004 Am J Epidemiol 169 8 2009 996 1003
9. C.B. Eaton, A.R. Abdul Baki, M.E. Waring, M.B. Roberts, and B. Lu The association of low selenium and renal insufficiency with coronary heart disease and all-cause mortality: NHANES III follow-up study Atherosclerosis 212 2 2010 689 694
10. S. Stranges, J.R. Marshall, and M. Trevisan Effects of selenium supplementation on cardiovascular disease incidence and mortality: secondary analyses in a randomized clinical trial Am J Epidemiol 163 8 2006 694 699
11. J.T. Salonen, G. Alfthan, J.K. Huttunen, J. Pikkarainen, and P. Puska Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study Lancet 2 8291 1982 175 179
12. K.M. Venardos, A. Perkins, J. Headrick, and D.M. Kaye Myocardial ischemia-reperfusion injury, antioxidant enzyme systems, and selenium: a review Curr Med Chem 14 14 2007 1539 1549
13. B. Moosmann, and C. Behl Selenoproteins, cholesterol-lowering drugs, and the consequences: revisiting of the mevalonate pathway Trends Cardiovasc Med 14 7 2004 273 281
14. A. Kalén, E.L. Appelkvist, and G. Dallner Age-related changes in the lipid compositions of rat and human tissues Lipids 24 7 1989 579 584
15. K. Folkers, S. Vadhanavikit, and S.A. Mortensen Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q10 Proc Natl Acad Sci U S A 82 3 1985 901 904
16. M. Senes, A.R. Erbay, and F.M. Yilmaz Coenzyme Q10 and high-sensitivity C-reactive protein in ischemic and idiopathic dilated cardiomyopathy Clin Chem Lab Med 46 3 2008 382 386
17. S.L. Molyneux, C.M. Florkowski, and P.M. George Coenzyme Q10: an independent predictor of mortality in chronic heart failure J Am Coll Cardiol 52 18 2008 1435 1441
18. K.K. Witte, N.P. Nikitin, and A.C. Parker The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure Eur Heart J 26 21 2005 2238 2244
19. S. Sander, C.I. Coleman, A.A. Patel, J. Klüger, and C.M. White The impact of coenzyme Q10 on systolic function in patients with chronic heart failure J Card Fail 12 6 2006 464 472
20. S.A. Mortensen Coenzyme Q10 as an adjunctive therapy in patients with congestive heart failure J Am Coll Cardiol 36 1 2000 304 305
21. M. de Lorgeril, and P. Salen Selenium and antioxidant defenses as major mediators in the development of chronic heart failure Heart Fail Rev 11 1 2006 13 17
22. K. Jensen-Urstad, F. Bouvier, and J. Hojer Comparison of different echocardiographic methods with radionuclide imaging for measuring left ventricular ejection fraction during acute myocardial infarction treated by thrombolytic therapy Am J Cardiol 81 5 1998 538 544
23. N. van Royen, C.C. Jaffe, and H.M. Krumholz Comparison and reproducibility of visual echocardiographic and quantitative radionuclide left ventricular ejection fractions Am J Cardiol 77 10 1996 843 850
24. E.H. Larsen, J.J. Sloth, M. Hansen, and S. Moesgaard Selenium speciation and isotope composition in 77Se-enriched yeast using gradient elution HPLC separation and ICP-dynamic reaction cell-MS J Anal At Spectrom 18 2003 310 316
25. E.H. Larsen, M. Hansen, H. Paulin, S. Moesgaard, M. Reid, and M. Rayman Speciation and bioavailability of selenium in yeast-based intervention agents used in cancer chemoprevention studies J AOAC Int 87 1 2004 225 232
26. S. Bugel, E.H. Larsen, and J.J. Sloth Absorption, excretion, and retention of selenium from a high selenium yeast in men with a high intake of selenium Food Nutr Res 52 2008
27. M. Weis, S.A. Mortensen, M.R. Rassing, J. Moller-Sonnergaard, G. Poulsen, and S.N. Rasmussen Bioavailability of four oral coenzyme Q10 formulations in healthy volunteers Mol Aspects Med 15 1994 s273 s280 [Suppl.]
28. K. Folkers, S. Moesgaard, and M. Morita A one year bioavailability study of coenzyme Q10 with 3 months withdrawal period Mol Aspects Med 15 1994 s281 s285 [Suppl.]
29. L. Xia, T. Nordman, and J.M. Olsson The mammalian cytosolic selenoenzyme thioredoxin reductase reduces ubiquinone. A novel mechanism for defense against oxidative stress J Biol Chem 278 4 2003 2141 2146
30. B. Kuklinski, E. Weissenbacher, and A. Fahnrich Coenzyme Q10 and antioxidants in acute myocardial infarction Mol Aspects Med 15 1994 s143 s147 [Suppl.]
31. S. Fumagalli, F. Fattirolli, and L. Guarducci Coenzyme Q10 terclatrate and creatine in chronic heart failure: a randomized, placebo-controlled, double-blind study Clin Cardiol 34 4 2011 211 217
32. E. Lubos, C.R. Sinning, and R.B. Schnabel Serum selenium and prognosis in cardiovascular disease: results from the AtheroGene study Atherosclerosis 209 1 2010 271 277
33. R.S. Lymbury, M.J. Marino, and A.V. Perkins Effect of dietary selenium on the progression of heart failure in the ageing spontaneously hypertensive rat Mol Nutr Food Res 54 10 Oct 2010 1436 1444
34. A. Jekell, A. Hossain, U. Alehagen, U. Dahlström, and A. Rosén Elevated circulating levels of thioredoxin and stress in chronic heart failure Eur J Heart Fail 6 7 2004 883 890